Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Aug;62(8):3270–3275. doi: 10.1128/iai.62.8.3270-3275.1994

Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus.

M Theisen 1, G Cox 1, B Høgh 1, S Jepsen 1, J Vuust 1
PMCID: PMC302955  PMID: 8039897

Abstract

The glurp gene of Plasmodium falciparum F32 has been inserted into a vaccinia virus, and the recombinant virus was designated VVG4. Expression of glurp in VVG4-infected Vero cells was analyzed by immunoprecipitation and revealed a primary GLURP product of approximately 220,000 Da; GLURP was detected both intracellularly and in culture supernatants. To study the immunogenicity of vaccinia virus-expressed GLURP, mice were immunized with VVG4 and serum samples were analyzed for antibody reactivity with three polypeptides, covering almost the entire GLURP molecule; these three polypeptides were produced in recombinant form in Escherichia coli. The immune response was primarily directed against a carboxy-terminal repeat region. The mouse anti-GLURP serum recognized authentic GLURP by immunoprecipitation analysis from P. falciparum grown in vitro. These results demonstrate that vaccinia virus-expressed glurp product can induce a humoral immune response against GLURP derived from blood-stage parasites.

Full text

PDF

Images in this article

3272Image
on p.3272
3273Image
on p.3273
3273Image
on p.3273
3274Image
on p.3274

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anders R. F., Coppel R. L., Brown G. V., Kemp D. J. Antigens with repeated amino acid sequences from the asexual blood stages of Plasmodium falciparum. Prog Allergy. 1988;41:148–172. [PubMed] [Google Scholar]
  2. Borre M. B., Dziegiel M., Høgh B., Petersen E., Rieneck K., Riley E., Meis J. F., Aikawa M., Nakamura K., Harada M. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol. 1991 Nov;49(1):119–131. doi: 10.1016/0166-6851(91)90135-s. [DOI] [PubMed] [Google Scholar]
  3. Boudin C., Chumpitazi B., Dziegiel M., Peyron F., Picot S., Hogh B., Ambroise-Thomas P. Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso. J Clin Microbiol. 1993 Mar;31(3):636–641. doi: 10.1128/jcm.31.3.636-641.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387–395. doi: 10.1093/nar/12.1part1.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dziegiel M., Borre M. B., Jepsen S., Hogh B., Petersen E., Vuust J. Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 1991 Mar;44(3):306–313. doi: 10.4269/ajtmh.1991.44.306. [DOI] [PubMed] [Google Scholar]
  6. Dziegiel M., Borre M. B., Petersen E., Högh B., Jepsen S., Vuust J., Axelsen N. Capture ELISA for IgM antibodies against Plasmodium falciparum glutamate rich protein. J Immunol Methods. 1992 Nov 5;155(2):207–213. doi: 10.1016/0022-1759(92)90287-4. [DOI] [PubMed] [Google Scholar]
  7. Dziegiel M., Rowe P., Bennett S., Allen S. J., Olerup O., Gottschau A., Borre M., Riley E. M. Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun. 1993 Jan;61(1):103–108. doi: 10.1128/iai.61.1.103-108.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hogh B., Petersen E., Dziegiel M., David K., Hanson A., Borre M., Holm A., Vuust J., Jepsen S. Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia. Am J Trop Med Hyg. 1992 Mar;46(3):307–313. doi: 10.4269/ajtmh.1992.46.307. [DOI] [PubMed] [Google Scholar]
  9. Kaslow D. C., Isaacs S. N., Quakyi I. A., Gwadz R. W., Moss B., Keister D. B. Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. Science. 1991 May 31;252(5010):1310–1313. doi: 10.1126/science.1925544. [DOI] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Lew A. M., Anders R. F., Edwards S. J., Langford C. J. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia. Immunology. 1988 Oct;65(2):311–314. [PMC free article] [PubMed] [Google Scholar]
  12. Lew A. M., Langford C. J., Pye D., Edwards S., Corcoran L., Anders R. F. Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia. J Immunol. 1989 Jun 1;142(11):4012–4016. [PubMed] [Google Scholar]
  13. Li S., Rodrigues M., Rodriguez D., Rodriguez J. R., Esteban M., Palese P., Nussenzweig R. S., Zavala F. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5214–5218. doi: 10.1073/pnas.90.11.5214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pye D., Edwards S. J., Anders R. F., O'Brien C. M., Franchina P., Corcoran L. N., Monger C., Peterson M. G., Vandenberg K. L., Smythe J. A. Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria. Infect Immun. 1991 Jul;59(7):2403–2411. doi: 10.1128/iai.59.7.2403-2411.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Satchidanandam V., Zavala F., Moss B. Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei. Mol Biochem Parasitol. 1991 Sep;48(1):89–99. doi: 10.1016/0166-6851(91)90167-5. [DOI] [PubMed] [Google Scholar]
  16. Tine J. A., Conseil V., Delplace P., De Taisne C., Camus D., Paoletti E. Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus. Infect Immun. 1993 Sep;61(9):3933–3941. doi: 10.1128/iai.61.9.3933-3941.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976 Aug 20;193(4254):673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]
  18. Van Dyke M. W., Sirito M., Sawadogo M. Single-step purification of bacterially expressed polypeptides containing an oligo-histidine domain. Gene. 1992 Feb 1;111(1):99–104. doi: 10.1016/0378-1119(92)90608-r. [DOI] [PubMed] [Google Scholar]
  19. van Drunen Littel-van den Hurk S., Parker M. D., Massie B., van den Hurk J. V., Harland R., Babiuk L. A., Zamb T. J. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine. 1993;11(1):25–35. doi: 10.1016/0264-410x(93)90336-v. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES